The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2020

Filed:

Oct. 20, 2016
Applicant:

Cerner Innovation, Inc., Kansas City, KS (US);

Inventors:

Alan M. Portnoy, Warwick, PA (US);

Deborah A. Saeger, Allentown, PA (US);

Assignee:

CERNER INNOVATION, INC., Kansas City, KS (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06F 19/00 (2018.01); G06Q 10/10 (2012.01); G06Q 50/24 (2012.01); G16H 10/60 (2018.01); A61M 5/14 (2006.01);
U.S. Cl.
CPC ...
G06F 19/3468 (2013.01); A61M 5/14 (2013.01); G06F 19/325 (2013.01); G06Q 10/1093 (2013.01); G06Q 50/24 (2013.01); G16H 10/60 (2018.01); A61M 2205/3576 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/6072 (2013.01);
Abstract

A system manages IV pumps so that clinicians automatically receive alerts, decisions, and actions required to maintain a patient IV medication therapy according to a prescribed treatment protocol. An infusion pump monitoring system, includes an acquisition processor for acquiring fluid infusion parameters for administration of an infusion fluid to a patient using an infusion pump. A fluid infusion monitor uses acquired fluid infusion parameters for automatically searching a patient medical record for information concerning rate of fluid infusion of a particular infusion fluid and determining if a rate of a previously administered dose of the particular infusion fluid was a lower rate than indicated in the fluid infusion parameters. An interface processor automatically initiates generation of a message indicating a potential adverse reaction to the particular infusion fluid in response to a determination of a lower rate being employed for previously administering the particular infusion fluid.


Find Patent Forward Citations

Loading…